Health & Community Living
This article was originally published in The Gray Sheet
Executive Summary
Plans to go public with a proposed offering of 600,000 shares of common stock priced at $6.00 per share, according to a registration statement filed with the Securities and Exchange Commission. The Gaithersburg, Maryland development-stage company makes the Hydra-Commode Lift and Stair-Climber devices for "physically challenged" individuals. The firm plans to use anticipated proceeds of $2.8 mil. to commence full-scale production and marketing of its products, for the acquisition of CamTec (a manufacturer of stainless steel medical equipment), the acquisition of "additional products and a distribution center," as well as for working capital, R&D and office equipment. Goldis Financial Group is underwriting the offering.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.